Invenomic Fund Investor Class shares
BIVRX
NASDAQ
| Weiss Ratings | BIVRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C- | |||
| Risk Index | Fair | |||
| Risk Grade | C+ | |||
| Company Info | BIVRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | Invenomic | |||
| Manager/Tenure (Years) | Benjamin R. Deschaine (7), Ali Motamed (7) | |||
| Website | http://www. invenomic.com | |||
| Fund Information | BIVRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | Invenomic Fund Investor Class shares | |||
| Category | Long-Short Equity | |||
| Sub-Category | Long/Short Equity | |||
| Prospectus Objective | Growth | |||
| Inception Date | Jun 19, 2017 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | 5,000.00 | |||
| Minimum Subsequent Investment | 500.00 | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | BIVRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 3.65% | |||
| Dividend | BIVRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 2.76% | |||
| Asset Allocation | BIVRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 85.88% | |||
| Stock | 14.12% | |||
| U.S. Stock | 0.46% | |||
| Non-U.S. Stock | 13.66% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | BIVRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -0.78% | |||
| 30-Day Total Return | -0.60% | |||
| 60-Day Total Return | -4.54% | |||
| 90-Day Total Return | -3.41% | |||
| Year to Date Total Return | -3.30% | |||
| 1-Year Total Return | -5.39% | |||
| 2-Year Total Return | -7.23% | |||
| 3-Year Total Return | 3.38% | |||
| 5-Year Total Return | 191.86% | |||
| Price | BIVRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | BIVRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $16.40 | |||
| 1-Month Low NAV | $16.40 | |||
| 1-Month High NAV | $17.02 | |||
| 52-Week Low NAV | $16.20 | |||
| 52-Week Low NAV (Date) | Jan 22, 2025 | |||
| 52-Week High NAV | $18.22 | |||
| 52-Week High Price (Date) | Mar 10, 2025 | |||
| Beta / Standard Deviation | BIVRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.14 | |||
| Standard Deviation | 12.59 | |||
| Balance Sheet | BIVRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 1.04B | |||
| Operating Ratios | BIVRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 3.42% | |||
| Turnover Ratio | 170.00% | |||
| Performance | BIVRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | -5.95% | |||
| Last Bear Market Total Return | 5.89% | |||